ERIC SCHMIDT

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Jack Anders, as Attorney-in-fact for Eric Schmidt
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ERIC SCHMIDT:

Company Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. Chief Financial Officer Common Stock 1,152,595 $3,658,798 $3.17 22 Mar 2023 Indirect
Allogene Therapeutics, Inc. Chief Financial Officer Common Stock 862,439 $2,737,726 $3.17 22 Mar 2023 Direct
Revolution Medicines, Inc. Director Common Stock 21,251 $573,777 $27.00 08 Jun 2023 Direct
Allogene Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 432,738 22 Mar 2023 Direct
RELMADA THERAPEUTICS, INC. Director Stock Option (right to buy) 150,000 25 May 2023 Direct
Revolution Medicines, Inc. Director Stock Option (Right to Buy) 18,400 08 Jun 2023 Direct

Insider Reports Filed by ERIC SCHMIDT

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RVMD Revolution Medicines, Inc. 08 Jun 2023 2 $0 4 Director 12 Jun 2023, 16:14
RLMD RELMADA THERAPEUTICS, INC. 25 May 2023 1 $0 4 Director 30 May 2023, 17:09
ALLO Allogene Therapeutics, Inc. 22 Mar 2023 2 $0 4 Chief Financial Officer 24 Mar 2023, 20:17
ALLO Allogene Therapeutics, Inc. 14 Mar 2023 1 -$196,258 4 Chief Financial Officer 16 Mar 2023, 17:08
RLMD RELMADA THERAPEUTICS, INC. 16 Dec 2022 1 $0 4 Director 20 Dec 2022, 16:33
RVMD Revolution Medicines, Inc. 16 Jun 2022 2 $0 4 Director 17 Jun 2022, 17:04
ALLO Allogene Therapeutics, Inc. 23 Mar 2022 2 $0 4 Chief Financial Officer 25 Mar 2022, 17:49
ALLO Allogene Therapeutics, Inc. 15 Mar 2022 1 -$87,551 4 Chief Financial Officer 17 Mar 2022, 17:58
RLMD RELMADA THERAPEUTICS, INC. 17 Dec 2021 1 $0 4 Director 26 May 2022, 18:41
RLMD RELMADA THERAPEUTICS, INC. 17 Dec 2021 1 $0 4 Director 21 Dec 2021, 20:31
RVMD Revolution Medicines, Inc. 22 Jun 2021 2 $0 4 Director 24 Jun 2021, 17:17
ALLO Allogene Therapeutics, Inc. 24 May 2021 2 +$271,423 4 Chief Financial Officer 26 May 2021, 08:00